The startup develops surgical assistance devices specifically designed for obstetricians to enhance the safety and efficiency of cesarean deliveries. By focusing on innovative medical technologies, the company aims to reduce complications and improve outcomes in women's health surgeries.
Funding
$8.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Obstetricians face challenges during cesarean deliveries, particularly with high BMI patients, including limited access and visualization of the surgical site, increasing the risk of complications for both mother and baby. Current surgical instruments may not adequately address these ergonomic challenges and potential safety concerns.
Solution
NUA Surgical develops the SteriCISION C-Section Retractor, a patented, single-use device designed to improve the ergonomics of cesarean section surgeries and reduce risk factors associated with surgical complications. The retractor enhances access and visualization within the surgical field, especially in challenging cases, contributing to safer outcomes for both the mother and the infant. By addressing unmet clinical needs identified and validated by clinicians, NUA Surgical aims to provide solutions that consider the perspectives of all key stakeholders involved in the delivery process.
Target Audience
The primary target audience includes obstetricians and their surgical teams performing cesarean deliveries, especially those seeking to improve safety and efficiency in procedures involving high BMI patients.
Features
- Patented, single-use C-Section Retractor designed for improved ergonomics during cesarean deliveries.
- Enhanced access and visualization of the surgical site, particularly beneficial for high BMI patients.
- Designed to reduce risk factors associated with surgical complications during C-sections.
- Addresses unmet clinical needs validated by clinicians globally.